Bvf Partners L P/Il's Net Worth

Bvf Partners L P/Il's net worth is estimated to be at least $448,431,563.97 as of 08/19/2022. CoreStreet's estimation of Bvf Partners L P/Il's net worth is based on their sale of stock and current holding of stock.

Bvf Partners L P/Il is Director at CTi Biopharma Corp. They have executed at least 99 trades of stock as per SEC Form 4 filings. Their most recent trade was for 7,210,566 units of CTIC stock on 08/09/2022. Their biggest sale was on 07/02/2021 when they sold 2,186,022 units of Merus NV stock for $45,359,956.50. They typically trade 11 times per year.

Total value of insider buys:
  • $234,397,595.92
Total value of insider sells:
  • $214,033,968.05
Most recent insider trade:
  • Aug. 9, 2022

Bvf Partners L P/Il's Insider Trading History

CTi Biopharma CorpTitleAmountPriceTypeTotal Value
Aug. 9, 2022
Director7,210,566$6.12Sell$44,128,663.92
April 1, 2021
Director2,000,000$2.50Buy$5,000,000.00
Feb. 9, 2018
Major Shareholder5,634,108$3.00Buy$16,902,324.00
Repare Therapeutics IncTitleAmountPriceTypeTotal Value
June 13, 2022
Major Shareholder149,161$12.73Buy$1,898,819.53
Olema Pharmaceuticals IncTitleAmountPriceTypeTotal Value
June 10, 2022
Director200,000$4.03Buy$806,000.00
Nov. 30, 2021
Director739,675$9.39Buy$6,945,548.25
Cullinan Oncology LLCTitleAmountPriceTypeTotal Value
June 1, 2022
Major Shareholder751,396$11.00Buy$8,265,356.00
April 1, 2022
Major Shareholder276,000$10.75Buy$2,967,000.00
Kymera Therapeutics IncTitleAmountPriceTypeTotal Value
May 26, 2022
Director224,057$14.21Buy$3,183,849.97
May 20, 2022
Director10,100$14.00Buy$141,400.00
May 5, 2022
Director150,000$19.60Buy$2,940,000.00
Jan. 31, 2022
Director34,408$40.70Buy$1,400,405.60
Jan. 27, 2022
Director95,901$38.33Buy$3,675,885.33
Jan. 24, 2022
Director272,767$37.76Buy$10,299,681.92
July 1, 2021
Director544,166$47.00Buy$25,575,802.00
Merus NVTitleAmountPriceTypeTotal Value
Oct. 7, 2021
Major Shareholder985,447$27.53Sell$27,129,355.91
July 2, 2021
Major Shareholder2,186,022$20.75Sell$45,359,956.50
March 22, 2021
Major Shareholder79,500$22.75Buy$1,808,625.00
March 16, 2021
Major Shareholder250,000$23.00Buy$5,750,000.00
Jan. 21, 2021
Major Shareholder844,680$24.75Buy$20,905,830.00
Dec. 18, 2020
Major Shareholder160,000$16.05Buy$2,568,000.00
Sept. 15, 2020
Major Shareholder146,754$11.75Buy$1,724,359.50
Sept. 10, 2020
Major Shareholder189,651$11.10Buy$2,105,126.10
Sept. 3, 2020
Major Shareholder201,906$11.17Buy$2,255,290.02
June 8, 2020
Major Shareholder87,254$15.20Buy$1,326,260.80
June 1, 2020
Major Shareholder1,462,510$14.00Buy$20,475,140.00
Jan. 16, 2020
Major Shareholder278,730$16.15Buy$4,501,489.50
Rain Therapeutics IncTitleAmountPriceTypeTotal Value
Sept. 13, 2021
Director392,269$16.49Buy$6,468,515.81
July 6, 2021
Director269,723$15.25Buy$4,113,275.75
July 1, 2021
Director317,279$15.65Buy$4,965,416.35
May 24, 2021
Director1,361$15.90Buy$21,639.90
May 21, 2021
Director121,986$15.94Buy$1,944,456.84
May 13, 2021
Director58,000$14.26Buy$827,080.00
XOMA CorpTitleAmountPriceTypeTotal Value
March 31, 2021
Director569,797$38.36Sell$21,857,412.92
Sept. 23, 2020
Director17,089$18.20Buy$311,019.80
Sept. 21, 2020
Director22,328$18.39Buy$410,611.92
Sept. 4, 2020
Director7,737$18.77Buy$145,223.49
Aug. 31, 2020
Director16,005$18.48Buy$295,772.40
Aug. 28, 2020
Director2,044$19.17Buy$39,183.48
Aug. 24, 2020
Director11,683$19.31Buy$225,598.73
Aug. 20, 2020
Major Shareholder1,772$19.12Buy$33,880.64
Aug. 18, 2020
Major Shareholder895$19.27Buy$17,246.65
Aug. 14, 2020
Major Shareholder21,922$18.69Buy$409,722.18
Aug. 12, 2020
Major Shareholder4,050$17.34Buy$70,227.00
March 25, 2020
Major Shareholder8,264$17.20Buy$142,140.80
March 13, 2020
Major Shareholder100,000$18.34Buy$1,834,000.00
Dec. 19, 2019
Major Shareholder373,195$22.00Buy$8,210,290.00
May 13, 2019
Major Shareholder3,797$14.36Buy$54,524.92
May 10, 2019
Major Shareholder10,300$14.57Buy$150,071.00
Dec. 12, 2018
Major Shareholder2,810$14.75Buy$41,447.50
Dec. 10, 2018
Major Shareholder18,081$14.54Buy$262,897.74
Dec. 6, 2018
Major Shareholder10,927$14.80Buy$161,719.60
Dec. 3, 2018
Major Shareholder806$14.90Buy$12,009.40
Nov. 29, 2018
Major Shareholder10,016$14.93Buy$149,538.88
Nov. 27, 2018
Major Shareholder11,396$15.24Buy$173,675.04
Nov. 21, 2018
Major Shareholder25,000$15.00Buy$375,000.00
Nov. 19, 2018
Major Shareholder9,771$13.93Buy$136,110.03
Nov. 15, 2018
Major Shareholder21,141$13.31Buy$281,386.71
Infinity Pharmaceuticals IncTitleAmountPriceTypeTotal Value
Jan. 22, 2021
Major Shareholder5,848,520$4.14Sell$24,212,872.80
Nov. 19, 2018
Major Shareholder1,465,126$1.37Buy$2,007,222.62
Nov. 15, 2018
Major Shareholder91,474$1.35Buy$123,489.90
Nov. 13, 2018
Major Shareholder604,208$1.35Buy$815,680.80
June 21, 2018
Major Shareholder425,531$1.65Buy$702,126.15
June 19, 2018
Major Shareholder3,516,560$1.65Buy$5,802,324.00
Cytokinetics IncTitleAmountPriceTypeTotal Value
Dec. 9, 2020
Insider430,954$18.00Sell$7,757,172.00
Feb. 13, 2020
Major Shareholder1,072,030$15.79Sell$16,927,353.70
Dec. 10, 2019
Major Shareholder223,659$9.40Buy$2,102,394.60
GlycoMimetics IncTitleAmountPriceTypeTotal Value
Nov. 4, 2020
Major Shareholder1,266,737$2.60Buy$3,293,516.20
Oct. 30, 2020
Major Shareholder932,612$2.75Buy$2,564,683.00
Sept. 5, 2019
Major Shareholder1,668,746$3.18Buy$5,306,612.28
Ideaya Biosciences IncTitleAmountPriceTypeTotal Value
June 30, 2020
Major Shareholder2,531$13.32Buy$33,712.92
June 22, 2020
Major Shareholder19,732$13.93Buy$274,866.76
June 19, 2020
Major Shareholder98,264$14.39Buy$1,414,018.96
Calithera Biosciences IncTitleAmountPriceTypeTotal Value
May 21, 2020
Major Shareholder2,283,598$6.00Sell$13,701,588.00
Nov. 20, 2019
Major Shareholder191,954$3.91Buy$750,540.14
Nov. 14, 2019
Major Shareholder128,488$3.37Buy$433,004.56
Oct. 29, 2019
Major Shareholder1,598,977$2.60Buy$4,157,340.20
Pieris Pharmaceuticals IncTitleAmountPriceTypeTotal Value
Sept. 6, 2019
Major Shareholder50,000$4.50Sell$225,000.00
Concert Pharmaceuticals IncTitleAmountPriceTypeTotal Value
June 10, 2019
Major Shareholder386,289$10.70Sell$4,133,292.30
Xenon Pharmaceuticals IncTitleAmountPriceTypeTotal Value
Aug. 15, 2017
Major Shareholder18,858$2.41Buy$45,447.78
Aug. 14, 2017
Major Shareholder41,344$2.70Buy$111,628.80
Alpine Immune Sciences IncTitleAmountPriceTypeTotal Value
June 7, 2017
Major Shareholder36,900$2.28Buy$84,132.00
June 5, 2017
Major Shareholder35,750$2.29Buy$81,867.50
ChemoCentryx IncTitleAmountPriceTypeTotal Value
June 10, 2015
Major Shareholder955,700$9.00Sell$8,601,300.00
Dec. 5, 2013
Major Shareholder189,800$5.01Buy$950,898.00
Nov. 6, 2013
Major Shareholder136,066$4.92Buy$669,444.72
Nov. 1, 2013
Major Shareholder336,225$4.99Buy$1,677,762.75
Oct. 9, 2013
Major Shareholder1,289,354$5.34Buy$6,885,150.36
Oct. 3, 2013
Major Shareholder109,425$5.49Buy$600,743.25
Sept. 13, 2013
Major Shareholder325,635$5.95Buy$1,937,528.25
Nov. 6, 2012
Major Shareholder40,000$12.00Buy$480,000.00
Rigel Pharmaceuticals IncTitleAmountPriceTypeTotal Value
June 7, 2013
Major Shareholder32,700$3.47Buy$113,469.00
Ligand Pharmaceuticals IncorporatedTitleAmountPriceTypeTotal Value
Jan. 23, 2013
Major Shareholder39,600$19.78Buy$783,288.00
Dec. 14, 2012
Major Shareholder5,386$18.63Buy$100,341.18
Dec. 6, 2012
Major Shareholder50,100$17.94Buy$898,794.00
Oct. 31, 2012
Major Shareholder16,591$15.19Buy$252,017.29
Catalyst Biosciences IncTitleAmountPriceTypeTotal Value
Nov. 16, 2012
Major Shareholder595,000$4.00Buy$2,380,000.00
Nov. 8, 2012
Major Shareholder72,429$4.03Buy$291,888.87
Nov. 2, 2012
Major Shareholder139,700$4.05Buy$565,785.00